| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Chain1
Departments of Pathology [E. W., G-Q. W., L. A. G., H. R.], and Otolaryngology [B. R. G.], The University of Pittsburgh School of Medicine, and The University of Pittsburgh Cancer Institute [H. R.], Pittsburgh, Pennsylvania 15213
We recently reported that the T-cell receptor (TCR)-
chain is cleaved bycaspase-3 and -7 in apoptotic T lymphocytes or in a cell-free system. Wereport here that the
chain is also a direct substrate for granzyme B (GrB) proteolytic activity. Loss in expression of TCR-
was observed in Jurkat T leukemic cells treated by a combination of GrB and a replication-deficient adenovirus. Although the apoptosis initiated in these cells by GrB was significantly reduced by the pancaspase inhibitor Z-VAD-FMK, TCR-
degradation was not prevented. These findings suggest that the GrB-mediated degradation of TCR-
chain can proceed despite the efficient inhibition of caspase activity. An in vitro translated TCR-
product was efficiently cleaved by GrB, which suggests that the TCR-
protein is a direct substrate for GrB. As assessed by site-directed mutagenesis, the activity of GrB was directed toward aspartic acid residues that were different from those of recombinant caspase-3. Whereas caspase-3 cleavage products appear to accumulate, the GrB-generated products seem to undergo further degradation, which suggests the presence of multiple GrB-specific cleavage sites within the TCR-
protein. These findings suggest that the TCR-
protein in target T lymphocytes serves as a substrate for the proteolytic activities that are featured by the two major mechanisms of cytotoxicity: death receptor pathways mediated by caspases and granule exocytosis mediated by direct GrB activity or GrB-activated caspases. TCR-
protein degradation may be of significance in cytotoxic mechanisms directed against T cells infected with viruses, such as HIV-1, in which the TCR-
protein is used for viral pathogenesis.
This article has been cited by other articles:
![]() |
C. L. Gorman, A. I. Russell, Z. Zhang, D. Cunninghame Graham, A. P. Cope, and T. J. Vyse Polymorphisms in the CD3Z Gene Influence TCR{zeta} Expression in Systemic Lupus Erythematosus Patients and Healthy Controls J. Immunol., January 15, 2008; 180(2): 1060 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ganor, V. I. Teichberg, and M. Levite TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage J. Immunol., January 15, 2007; 178(2): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. von Essen, C. M. Bonefeld, V. Siersma, A. B. Rasmussen, J. P. H. Lauritsen, B. L. Nielsen, and C. Geisler Constitutive and Ligand-Induced TCR Degradation J. Immunol., July 1, 2004; 173(1): 384 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Han, L. A. Goldstein, B. R. Gastman, C. J. Froelich, X.-M. Yin, and H. Rabinowich Degradation of Mcl-1 by Granzyme B: IMPLICATIONS FOR Bim-MEDIATED MITOCHONDRIAL APOPTOTIC EVENTS J. Biol. Chem., May 21, 2004; 279(21): 22020 - 22029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Clark, A. E. Annenkov, M. Panesar, P. Isomaki, Y. Chernajovsky, and A. P. Cope T cell receptor {zeta} reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor {alpha} PNAS, February 10, 2004; 101(6): 1696 - 1701. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |